Eventide Asset Management »

Tg Therapeutics shares owned by Eventide Asset Management

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Eventide Asset Management from 13F filings

Historical chart of Eventide Asset Management investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Eventide Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $17M 719k 23.39
2024-06-30 $13M 719k 17.79
2024-03-31 $11M 719k 15.21
2023-12-31 $7.5M 440k 17.08
2016-12-31 $2.5M 538k 4.65
2016-09-30 $4.2M 538k 7.74
2016-06-30 $3.3M 538k 6.06
2016-03-31 $4.6M 538k 8.52
2015-12-31 $6.4M 538k 11.93
2015-09-30 $3.8M 376k 10.08
2015-06-30 $4.5M 271k 16.59
2015-03-31 $2.8M 183k 15.48
2014-12-31 $2.5M 155k 15.84
2014-09-30 $1.7M 155k 10.67
2014-06-30 $1.3M 135k 9.39